FY2023 Earnings Estimate for Transcat, Inc. (NASDAQ:TRNS) Issued By HC Wainwright

Transcat, Inc. (NASDAQ:TRNS – Get Rating) – Equities research analysts at HC Wainwright dropped their FY2023 earnings estimates for shares of Transcat in a report issued on Monday, May 15th. HC Wainwright analyst S. Buck now expects that the scientific and technical instruments company will post earnings per share of $1.29 for the year, down from their prior estimate of $1.39. HC Wainwright currently has a “Buy” rating and a $96.00 target price on the stock. The consensus estimate for Transcat’s current full-year earnings is $1.33 per share. HC Wainwright also issued estimates for Transcat’s Q4 2023 earnings at $0.37 EPS, Q1 2024 earnings at $0.30 EPS, Q2 2024 earnings at $0.28 EPS and Q4 2024 earnings at $0.51 EPS.

Several other equities research analysts have also recently commented on TRNS. Northland Securities lifted their price target on shares of Transcat from $90.00 to $100.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 1st. Roth Capital boosted their price objective on shares of Transcat from $80.00 to $94.00 and gave the stock a “buy” rating in a research report on Thursday, February 2nd. StockNews.com started coverage on shares of Transcat in a report on Thursday, March 16th. They issued a “hold” rating on the stock. Finally, Craig Hallum upped their price objective on shares of Transcat from $81.00 to $92.00 and gave the company a “buy” rating in a report on Wednesday, February 1st. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $95.50.

Transcat Trading Down 3.2 %

Shares of TRNS stock opened at $82.59 on Tuesday. Transcat has a 12-month low of $50.32 and a 12-month high of $91.71. The company has a market capitalization of $624.51 million, a P/E ratio of 62.56 and a beta of 0.77. The company has a quick ratio of 1.75, a current ratio of 2.42 and a debt-to-equity ratio of 0.49. The firm has a 50-day moving average price of $83.74 and a 200 day moving average price of $81.38.

Hedge Funds Weigh In On Transcat

Several institutional investors and hedge funds have recently modified their holdings of TRNS. US Bancorp DE grew its stake in shares of Transcat by 137.9% in the first quarter. US Bancorp DE now owns 345 shares of the scientific and technical instruments company’s stock valued at $28,000 after acquiring an additional 200 shares in the last quarter. Altshuler Shaham Ltd acquired a new position in shares of Transcat in the first quarter valued at about $30,000. Dorsey Wright & Associates acquired a new position in shares of Transcat in the fourth quarter valued at about $39,000. BNP Paribas Arbitrage SA grew its stake in shares of Transcat by 162.3% in the second quarter. BNP Paribas Arbitrage SA now owns 1,626 shares of the scientific and technical instruments company’s stock valued at $92,000 after acquiring an additional 1,006 shares in the last quarter. Finally, Barclays PLC grew its stake in Transcat by 533.1% during the fourth quarter. Barclays PLC now owns 1,912 shares of the scientific and technical instruments company’s stock worth $135,000 after buying an additional 1,610 shares in the last quarter. 83.24% of the stock is currently owned by institutional investors and hedge funds.

Transcat Company Profile

(Get Rating)

Transcat, Inc engages in provision of calibration and laboratory instrument services. It operates through the Service and Distribution segments. The Service segment offers calibration, repair, inspection, analytical qualifications, preventive maintenance, consulting, and other related services. The Distribution segment distributes professional grade test, measurement, and control instrumentation.